These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Upregulation of axon guidance molecules in the adult central nervous system of Nogo-A knockout mice restricts neuronal growth and regeneration. Kempf A; Montani L; Petrinovic MM; Schroeter A; Weinmann O; Patrignani A; Schwab ME Eur J Neurosci; 2013 Dec; 38(11):3567-79. PubMed ID: 24103058 [TBL] [Abstract][Full Text] [Related]
14. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury. Kim JE; Liu BP; Park JH; Strittmatter SM Neuron; 2004 Oct; 44(3):439-51. PubMed ID: 15504325 [TBL] [Abstract][Full Text] [Related]
15. Effects of PTEN and Nogo Codeletion on Corticospinal Axon Sprouting and Regeneration in Mice. Geoffroy CG; Lorenzana AO; Kwan JP; Lin K; Ghassemi O; Ma A; Xu N; Creger D; Liu K; He Z; Zheng B J Neurosci; 2015 Apr; 35(16):6413-28. PubMed ID: 25904793 [TBL] [Abstract][Full Text] [Related]
16. Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury. Li S; Strittmatter SM J Neurosci; 2003 May; 23(10):4219-27. PubMed ID: 12764110 [TBL] [Abstract][Full Text] [Related]
17. Limiting Neuronal Nogo Receptor 1 Signaling during Experimental Autoimmune Encephalomyelitis Preserves Axonal Transport and Abrogates Inflammatory Demyelination. Lee JY; Kim MJ; Thomas S; Oorschot V; Ramm G; Aui PM; Sekine Y; Deliyanti D; Wilkinson-Berka J; Niego B; Harvey AR; Theotokis P; McLean C; Strittmatter SM; Petratos S J Neurosci; 2019 Jul; 39(28):5562-5580. PubMed ID: 31061088 [TBL] [Abstract][Full Text] [Related]
18. The Nogo-Nogo receptor pathway limits a spectrum of adult CNS axonal growth. Cafferty WB; Strittmatter SM J Neurosci; 2006 Nov; 26(47):12242-50. PubMed ID: 17122049 [TBL] [Abstract][Full Text] [Related]
19. Characterization of myelin ligand complexes with neuronal Nogo-66 receptor family members. Laurén J; Hu F; Chin J; Liao J; Airaksinen MS; Strittmatter SM J Biol Chem; 2007 Feb; 282(8):5715-25. PubMed ID: 17189258 [TBL] [Abstract][Full Text] [Related]
20. The Soluble Form of LOTUS inhibits Nogo Receptor-Mediated Signaling by Interfering with the Interaction Between Nogo Receptor Type 1 and p75 Neurotrophin Receptor. Kawakami Y; Kurihara Y; Saito Y; Fujita Y; Yamashita T; Takei K J Neurosci; 2018 Mar; 38(10):2589-2604. PubMed ID: 29440387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]